Category Archives: Cancer News

Software company to recruit people with autism as programmers

German software company SAP is looking to recruit people with autism as programmers and product testers, drawing on skills that can include a close attention to detail and an ability to solve complex problems. SAP has asked start-up Danish recruitment company Specialisterne to help it find, train and manage employees diagnosed with the disability. “They bring a special set of skills to the table, which fits with SAP,” said a spokesman for the company, which has already hired people with autism in India and Ireland. Specialisterne Chief Executive Steen Thygesen said the partnership was his first with a multinational company to help with its worldwide recruitment. The Danish company says it has already helped several hundred autistic people to find a job. Sufferers often find it harder to communicate and some have lifelong learning disabilities. Those with a form of autism known as Asperger syndrome can sometimes have above-average intelligence. As children, they may prefer mathematics and other subjects rooted in logic and systems, according to Britain's National Autistic Society. “People with autism have some unique abilities to really focus on their task and stay focused for long periods of time. They are also good at spotting discrepancies in data,” said Thygesen, a former manager with Microsoft and Nokia whose 14-year-old son has Asperger syndrome. According to the U.S. Centers for Disease Control and Prevention, 1 in every 88 children in the United States and almost 1 in 54 boys are diagnosed with autism. The SAP spokesman said the company aimed to reflect the proportion of people diagnosed as autistic in society within its 65,000-strong workforce - or about 1 percent. A Berlin-based company, Auticon, already exclusively employs autistic people as software testers. It has a team analyzing data for Vodafone Germany, an Auticon spokesman said.source : http://www.foxnews.com/health/2013/05/22/software-company-to-recruit-people-with-autism-as-programmers/

Could eating less save your brain? Study shows reducing calories delays nerve cell loss

Calorie restriction may not always be fun, but cutting back has benefits beyond even weight loss. Studies have shown that eating less can help slow aging, prolong life and even decrease the effects of diseases like Alzheimer’s in a variety of organisms. Based on this knowledge, a group of researchers from the Massachusetts Institute of Technology (MIT) decided to dig further and ask: Could calorie restriction also delay nerve cell loss in the brain – and the changes in learning and memory that go along with it? “We reasoned – and other folks reasoned – that because cognitive decline and neurodegeneration are characteristics of the aging process, that calorie restriction might also work in the brain to slow neurodegeneration,” lead study author, Dr. Johannes Gräff from the Picower Institute for Learning and Memory at MIT, and Howard Hughes Medical Institute, told FoxNews.com. Gräff and his colleagues tested their theory using a group of mice engineered to experience rapid neurodegeneration. Researchers decreased half of the mice’s calorie intake by 30 percent and kept the remaining mice on a normal diet. After three months, researchers tested the learning and memory skills in each group of mice, expecting to see a decline in both cognitive areas. However, while the mice eating normally showed evidence of significant learning and memory deficits related to nerve cell loss, the calorie-restricted mice showed no defecits in their learning or memory skills. “That was one of the first experiments we did, and that was quite promising and cool that it worked,” Gräff said. In the next phase of the study, researchers took a more in-depth look at the brains of both groups of mice. “What we further did was to look through the brains to check the extent or amount of neurodegeneration, and what we found was that neurodegeneration had been slowed down by calorie restriction,” Gräff said. Researchers were curious if reduced neurodegeneration could still be achieved by utilizing proteins activated during calorie restriction – without actually restricting calories. Eventually, they targeted an enzyme called Sirtuin 1 (SIRT1). “This protein is one candidate that has been known to be more abundantly expressed as a result of calorie restriction in our tissues,” Gräff said. The scientists then gave a separate group of mice, also engineered to experience rapid neurodegeneration, a pharmacological dose of SIRT1, without restricting their calorie intake. These mice experienced the same effects as the calorie-restricted mice, showing slower rates of nerve cell loss and no learning or memory deficits after a three-month period. Graff noted that more research needed to be done in this area, and he hopes to further explore the relationship between calorie restriction, SIRT1 and neurodegeneration. “We have the choice – (to look into how) to reduce calorie intake in order to slow onset of neurodegeneration, or we look to this pharmacological activator (to do the same thing),” Gräff said. “Do you want to engage more into reducing caloric intake or revert to pharmacological means for the same effect?” This study is published in the May 22nd issue of The Journal of Neuroscience.source : http://www.foxnews.com/health/2013/05/22/could-eating-less-save-your-brain-study-shows-reducing-calorie-intake-delays/

Study details genes that control whether tumors adapt or die when faced with p53 activating drugs

"The gene p53 is one of the most commonly mutated cancer genes. Tumors turn it off and then they can avoid controls that should kill them. Fine: we have drugs that can reactivate p53. But the bad news is when we go into the clinic with these drugs, only maybe one in ten tumors actually dies. …

Could eating less save your brain? Study shows reducing calorie intake delays nerve cell loss

Calorie restriction may not always be fun, but cutting back has benefits beyond even weight loss. Studies have shown that eating less can help slow aging, prolong life and even decrease the effects of diseases like Alzheimer’s in a variety of organisms. Based on this knowledge, a group of researchers from the Massachusetts Institute of Technology (MIT) decided to dig further and ask: Could calorie restriction also delay nerve cell loss in the brain – and the changes in learning and memory that go along with it? “We reasoned – and other folks reasoned – that because cognitive decline and neurodegeneration are characteristics of the aging process, that calorie restriction might also work in the brain to slow neurodegeneration,” lead study author, Dr. Johannes Gräff from the Picower Institute for Learning and Memory at MIT, and Howard Hughes Medical Institute, told FoxNews.com. Gräff and his colleagues tested their theory using a group of mice engineered to experience rapid neurodegeneration. Researchers decreased half of the mice’s calorie intake by 30 percent and kept the remaining mice on a normal diet. After three months, researchers tested the learning and memory skills in each group of mice, expecting to see a decline in both cognitive areas. However, while the mice eating normally showed evidence of significant learning and memory deficits related to nerve cell loss, the calorie-restricted mice showed no defecits in their learning or memory skills. “That was one of the first experiments we did, and that was quite promising and cool that it worked,” Gräff said. In the next phase of the study, researchers took a more in-depth look at the brains of both groups of mice. “What we further did was to look through the brains to check the extent or amount of neurodegeneration, and what we found was that neurodegeneration had been slowed down by calorie restriction,” Gräff said. Researchers were curious if reduced neurodegeneration could still be achieved by utilizing proteins activated during calorie restriction – without actually restricting calories. Eventually, they targeted an enzyme called Sirtuin 1 (SIRT1). “This protein is one candidate that has been known to be more abundantly expressed as a result of calorie restriction in our tissues,” Gräff said. The scientists then gave a separate group of mice, also engineered to experience rapid neurodegeneration, a pharmacological dose of SIRT1, without restricting their calorie intake. These mice experienced the same effects as the calorie-restricted mice, showing slower rates of nerve cell loss and no learning or memory deficits after a three-month period. Graff noted that more research needed to be done in this area, and he hopes to further explore the relationship between calorie restriction, SIRT1 and neurodegeneration. “We have the choice – (to look into how) to reduce calorie intake in order to slow onset of neurodegeneration, or we look to this pharmacological activator (to do the same thing),” Gräff said. “Do you want to engage more into reducing caloric intake or revert to pharmacological means for the same effect?” This study is published in the May 22nd issue of The Journal of Neuroscience.source : http://www.foxnews.com/health/2013/05/22/could-eating-less-save-your-brain-study-shows-reducing-calorie-intake-delays/

Cold plasma successful against brain cancer cells, study suggests

If someone is diagnosed with the type of brain tumour called glioblastoma, the prospects are dire: median survival is just a bit over one year, and less than 16 % of the patients survive more than three years. It is still unknown how this cancer is triggered — only a few rare genetic factors have been identified so far — and treatment remains largely palliative, i.e. trying to alleviate the symptoms and prolonging the life of the patient. …

Inexpensive, accurate way to detect prostate cancer: At-home urine tests

After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy and at dramatically lower cost. The same technology could potentially be used for bladder and multiple myeloma cancers, which also shed identifiable markers in urine. "Our goal is a device the size of a home pregnancy test priced around $10…

American Cancer Society turns 100 as cancer rates fall

The American Cancer Society - one of the nation's best known and influential health advocacy groups - is 100 years old this week. Back in 1913 when it was formed, cancer was a lesser threat for most Americans. The biggest killers then were flu, pneumonia, tuberculosis, and stomach bugs. At a time when average life expectancy was 47, few lived long enough to get cancer. But 15 doctors and businessmen in New York City thought cancer deserved serious attention, so they founded the American Society for the Control of Cancer. The modern name would come 31 years later. The cancer society's rise coincided with the taming of infectious diseases and lengthening life spans. “Cancer is a disease of aging, so as people live longer there will be more cancer,” explained Dr. Michael Kastan, executive director of Duke University's Cancer Institute. Cancer became the nation's No. 2 killer in 1938, a ranking it has held ever since. It also became perhaps the most feared disease - the patient's own cells growing out of control, responding only to brutal treatments: surgery, radiation and poisonous chemicals. The cancer society is credited with being the largest and most visible proponent of research funding, prevention and programs to help house and educate cancer patients. Last year, the organization had revenues of about $925 million. It employs 6,000 and has 3 million volunteers, calling itself the largest voluntary health organization in the nation. “The American Cancer Society really is in a league of its own,” Kastan said. The rate of new cancer cases has been trending downward ever so slightly. Some historical highlights: 1913 - The American Society for the Control of Cancer is founded in New York City. 1944 - The organization is renamed the American Cancer Society. The change is spurred by Mary Lasker, the wife of advertising mogul Albert Lasker. 1946 - A research program is launched, built on $1 million raised by Mary Lasker. A year later, Dr. Sidney Farber of Boston announces the first successful chemotherapy treatment. 1948 - The cancer society pushes the Pap test, which has been credited with driving a 70 percent decline in uterine and cervical cancer. 1964 - Prodded by the cancer society and other groups, U.S. Surgeon General Luther Terry issues a report irrefutably linking smoking to cancer. 1971 - The cancer society helps lead passage of the National Cancer Act to ramp up research money. President Nixon declares a national “war on cancer,” which becomes an extended effort derided by some as a “medical Vietnam.” 1976 - The cancer society suggests women 40 and older consider a mammogram if their mother or sisters had breast cancer. 1976 - The cancer society hosts a California event to encourage smokers to quit for the day. A year later, the annual Great American Smokeout is launched nationally. 1988 - Atlanta becomes headquarters for the society. 1997 - The cancer society recommends yearly mammograms for women over 40. 2000 - Dr. Brian Druker of Oregon reports the first success with “targeted” cancer therapy. 2003 - The cancer society stops recommending monthly breast self-exams. But it continues to urge annual mammograms for most women over 40, even after a government task force says most don't need screening until 50. 2012 - The cancer society reports the rate of new cancer cases has been inching down by about half a percent each year since 1999.source : http://www.foxnews.com/health/2013/05/22/american-cancer-society-turns-100-as-us-cancer-rates-fall/

Antidepressants may help with heart disease

For some patients with heart disease, taking antidepressants may reduce the risk of heart problems brought on by mental stress, a new study suggests. Researchers looked at patients with myocardial ischemia a condition in which the heart doesn't get enough blood as they preformed mentally stressful activities. All of the patients also had coronary heart disease, or a narrowing of the arteries that supply blood to the heart. Patients in the study who took the antidepressant escitalopram (sold as Lexapro) were about 2.5 times less likely than those who took a placebo to experience myocardial ischemia triggered by mental stress. The findings suggest that an antidepressant, or other treatments that help patients cope with stress, could improve symptoms for some people with coronary heart disease, said study researcher Dr. Wei Jiang, an associate professor of psychiatry and behavioral sciences at Duke University School of Medicine. However, future studies are needed to confirm the results, and to identify the people most likely to benefit from such treatment, Jiang said. Stress and the heart About 30 years ago, doctors observed that mental stress could bring on myocardial ischemia.tudies also have found that people with mental-stress-induced myocardial ischemia are at increased risk of dying from heart disease. Coronary heart disease is the leading cause of death in the United States and about 50 percent of patients with the condition experience mental-stress-induced myocardial ischemia yet few studies have attempted to find treatments. In the new study, 127 patients were randomly assigned to receive escitalopram or placebo for six weeks. Participants completed a number of tests at the beginning and end of the study, including a treadmill stress test, a math test and a test in which participants told a sad story in order to evoke emotion. During the tests, the researchers examined certain heart symptoms to diagnose myocardial ischemia, such as a reduction in blood pumped out of one of the heart's cambers. After six weeks, about 34 percent of participants taking the antidepressant did not experience myocardial ischemia during the mental-stress tests, compared with 17 percent in the placebo group. The antidepressant did not affect whether patients experienced myocardial ischemia during exercise. Dr. Andrew Freeman, a cardiologist at the National Jewish Health hospital in Denver, said it was not very surprising that drugs that blunt the brain's response to stress would also blunt the heart's response to stress. But what the findings mean for patients in the long term is not known, said Freeman, who was not involved in the study. Future studies are needed to see whether antidepressants might reduce the risk of cardiovascular events like heart attacks, Freeman said. How does it work?